Strive Asset Management’s Bold Bet: How $750 Million in Biotech Can Fuel Bitcoin Fortune!

Strive Asset Management Targets Biotechnology for Bitcoin Strategy In a bold move blending two distinct sectors, Vivek Ramaswamy’s firm, Strive Asset Management, has earmarked $750 million to acquire struggling biotechnology companies as a means to gamble on the soaring cryptocurrency, bitcoin (BTC). This strategy, recently detailed following Strive’s reverse merger with Asset Entities Inc. (ASST), […]


